Drug shortages impact patient care. The SCCM Drug Shortages and Medication Safety Committee has resources to help. Check out https://t.co/qFOqBRPlxS and see below for managing the IV ACLS medication shortages.
@SCCM#SCCMSoMe#DrugShortages#MedicationSafety#ACLSAlert
Drug shortages impact patient care. The @SCCM Drug Shortages and Medication Safety Committee has resources to help! See below for tips on managing parenteral antiseizure medication shortages!
For more info ⏩ https://t.co/WbieT6m6O8…
#DrugShortages#MedSafety#PharmICU
Drug shortages impact patient care. The SCCM Drug Shortages and Medication Safety Committee has resources to help. Check out https://t.co/rA7FHfG53I and see below for managing thrombolytics drug shortage. @SCCM#SCCMSoMe#DrugShortages#MedicationSafety#thrombolytics
Honored to have received the inaugural @MDAndersonNews Clinical Pharmacist of the Year Award! Thank you to my pharmacy peers for this recognition. #PharmICU
📣 Dr. @AnneRainRX is one of 8 strong candidates for the CPP Section Member-at-Large (MAL) position.
Cast your vote for Secretary/Treasurer and MAL by 12/19 at 11:59 pm CT on Connect: https://t.co/nWrDpbs4k3
#PharmICU
✅ Voting for CPP Section Steering Committee leadership is now open! The CPP Section must elect 1 Member at-Large and 1 Secretary/Treasurer.
🗓️ Cast your vote by 12/19 at 11:59 CT.
📩 Check Connect for more details on how to cast your vote! https://t.co/nWrDpbs4k3
#PharmICU
Our @SCCM#DrugShortages and #MedicationSafety Committee continues to develop great resources to guide clinicians. Check out this infographic and more resources on the website. #SCCMSoMe
Drug shortages have significant impact on patient care! The SCCM Drug Shortages and Medication Safety Committee has resources to help. https://t.co/mWZDsrwfkn and see below for key points in managing IV lorazepam shortage @SCCM#SCCMSoMe #DrugShortagesandMedicationSafety#BZDAlert
“The alternative to CPR, D.N.R., tends to inspire fear rather than trust. A newer phrase, “allow natural death” (A.N.D.), avoids the suggestion that other treatments are being withheld.”
“CPR has become an expectation rather than an exception, a treatment meant for a few but applied to all.”
“The result, done correctly, is akin to assault.”
New in #JPEN early view: Proinflammatory mediators in lipid emulsions and parenteral-nutrition associated liver disease: Review of leading factors. https://t.co/AFzUgdBHip
As the end of the residency training cycle approaches, residents are likely focused on completing program requirements or securing a FT position. Something likely not on their radar is considering their identity and/or purpose after graduation. Read more: https://t.co/OaMfvLPjOx
Today we host Day #1 of our 2- Day Annual DOP Research and Quality Celebration. Over 2 days the Division tunes in to hear 20 select platform presentations of research & quality projects completed this year @MDAndersonNews@rouxpharm
via @NYTimes today - “The lack of transparency is itself a problem, not only for A.D.H.D. medications but for other drug shortages. If the public and policymakers don’t know what’s going wrong, they can’t help find a solution.” https://t.co/N6Y7JczmCf
Join us on tomorrow for the Pharmacy #HCT Core Topics live session, which will focus on #GVHD and #CARTcells. If you’re a PGY2 oncology pharmacy resident or interested trainee you won’t want to miss this. Register for free now: https://t.co/WwCPMfgK5f